Covestor LTD Acadia Pharmaceuticals Inc Transaction History

Covestor LTD

$181 Million
Q3 2025

A detailed history of Covestor LTD transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Covestor LTD holds 10,414 shares of ACAD stock, worth $250,144. This represents 0.12% of its overall portfolio holdings.

Number of Shares

10,414

Previous 15,985 34.85%

Holding current value

$250,144

Previous $345,000 35.65%

% of portfolio

0.12%

Previous 0.2%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 30, 2025	SELL	$20.88 - $26.57 $116,322 - $148,021	-5,571 Reduced 34.85%	10,414 $222,000
Q2 2025 Aug 11, 2025	BUY	$14.1 - $22.95 $213,403 - $347,348	15,135 Added 1780.59%	15,985 $345,000
Q1 2025 May 12, 2025	BUY	$16.61 - $20.29 $99 - $121	6 Added 0.71%	850 $15,000
Q4 2024 Feb 13, 2025	BUY	$14.29 - $18.76 $2,500 - $3,283	175 Added 26.16%	844 $16,000
Q3 2024 Nov 01, 2024	SELL	$15.14 - $19.14 $30 - $38	-2 Reduced 0.3%	669 $10,000

Q2 2024 Aug 09, 2024	SELL	$14.62 - $18.42 $19,897 - $25,069	-1,361 Reduced 66.98%	671 $11,000
Q1 2024 May 10, 2024	BUY	$17.79 - $30.86 $14,943 - $25,922	840 Added 70.47%	2,032 $38,000
Q4 2023 Feb 09, 2024	BUY	$20.78 - $31.77 $12,634 - $19,316	608 Added 104.11%	1,192 $37,000
Q3 2023 Nov 13, 2023	BUY	$20.84 - $33.47 $11,920 - $19,144	572 Added 4766.67%	584 $12,000
Q1 2023 May 15, 2023	SELL	$16.32 - $20.92 $48 - $62	-3 Reduced 20.0%	12 $0
Q4 2022 Feb 13, 2023	SELL	$14.2 - $18.63 $198 - $260	-14 Reduced 48.28%	15 $0
Q3 2022 Nov 14, 2022	BUY	$14.11 - $18.27 $141 - $182	10 Added 52.63%	29 $0
Q2 2022 Aug 10, 2022	SELL	$13.01 - $27.22 $1,860 - $3,892	-143 Reduced 88.27%	19 $0
Q1 2022 May 13, 2022	SELL	$20.94 - $27.5 $125 - $165	-6 Reduced 3.57%	162 $4,000
Q4 2021 Feb 10, 2022	BUY	$16.79 - $27.09 $2,820 - $4,551	168 New	168 $4,000

Others Institutions Holding ACAD

# of Institutions

375

Shares Held

162M

Call Options Held

1.47M

Put Options Held

1.1M

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.89B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account